1 / 34

“A PARTNERSHIP IN HEALTH & WELLNESS”

SourceOne Global Partners. “A PARTNERSHIP IN HEALTH & WELLNESS”. Presentation Agenda. Introductions, SourceOne and Vesifact What is the VESIsorb ® delivery system How it works, the features and benefits “Seeing is believing” Providing science-based solutions… Global market leadership….

dean
Download Presentation

“A PARTNERSHIP IN HEALTH & WELLNESS”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. SourceOne Global Partners “A PARTNERSHIP IN HEALTH & WELLNESS”

  2. Presentation Agenda • Introductions, SourceOne and Vesifact • What is the VESIsorb® delivery system • How it works, the features and benefits • “Seeing is believing” • Providing science-based solutions… • Global market leadership…

  3. SourceOne Global Partners“Our Success Insures Your Success” We provide health and wellness solutions, created through scientific research and innovative product development. Our focus is on clinically proven formulations, combined with technologically-advanced and patented delivery systems

  4. The SourceOne Difference • SourceOne has distinguished itself as a premier innovator of scientifically proven health products and technologies. • Our leadership team has forged numerous global partnerships and alliances resulting in competitive advantages and added value to the portfolio we bring to the global marketplace. • The synergies created by these partnerships are directly and immediately applicable to the new products we are introducing and those we are developing. • The many benefits derived from these innovations and the technology exchange will resonate with our client partners and ultimately the consumer focused on health and wellness.

  5. Exclusive Partnership with World Leader in advanced delivery systems Through SourceOne’s exclusive partnership with Vesifact, a world leader in micro emulsions, nano-colloids, drug delivery, and other innovative delivery systems, we are a leading solution provider for dramatically improving absorption and bioavailability of poorly absorbed ingredients.

  6. Vesifact Swiss Precision, Closed Loop Sterile Production Facility

  7. The latest breakthrough is VESIsorb® What is VESIsorb®? A naturally self-assembling colloidal delivery system that enables us to meet the growing demand for enhanced bioavailability of unique science-based formulas taking their absorption and efficacy to the next level.

  8. Self-Assembling Delivery System VESIsorb® keeps water insoluble respectively fat soluble molecules in a hydrophilic environment (e.g. water, gastric fluids) in solution. VESIsorb® does not change a molecule chemically. It is a solubilizing vehicle comprising an oil core surrounded by a monolayer membrane (emulsifiers). These emulsifiers link the two surface areas between water and oil. Without “linking molecules”, it is impossible to get a stable oil/water mixture (emulsion). This is a dynamic process, no static, and it allows the molecules (emulsifiers, oils, actives) to move perpetually from one droplet to another or other membranes (e.g. enterocytes).

  9. VESIsorb®…Three Step Process

  10. Advantages in Technology “H2O” Colloidal solubilized active CoQsource® • Non-aqueous lipid-basedcomposition containing an active ingredient • On contact with an aqueous phase a colloidal delivery system containing the active ingredients is spontaneously formed (self-assembling) • Superior Characteristics of the colloidal delivery system • Size <100nm, typically <50nm • Highly uniform size distribution

  11. Patented All-Natural Delivery System CoQ10 Colloid Phase CoQsource® CoQ10 Pre-Colloid Phase CoQ10(Ubiquinone)

  12. Micelle vs. Liposome vs. Colloidal Delivery System • Colloidal • Shell: Mono-layer • Core: Oil Liposome • Shell: Bi-Layer • Core: Water Micelle Shell: Hydrophilic surfactant head Core: Hydrophobic surfactant tail

  13. CoQ10 Bio-enhanced formulations compare absorption data to CoQ10 powders 3 studies show peak absorption of CoQ10 powder of .51, .85 and 2.15 average = 1.17 3 studies using soft gels in oily dispersion show peak absorption…1.32, 1.76 and 1.98 average = 1.69 3 studies various delivery systems… 2.24, 3.57, and 4.48 average = 3.43 VESIsorb® colloidal droplet peak absorption… 16.97

  14. Published Study Results The graph above provides a vivid illustration of the difference in CoQsource® (orange line) versus the three other “bio-enhanced” CoQ10 products in plasma concentration levels after one hour, but continues to increase dramatically before reaching Cmax at about 4 hours. The plasma concentration of CoQsource® remains well above the levels of the 3 other treatments throughout the 23 hour period.

  15. Consistent Clinical ResultsCoQ10 Ubiquinone & Ubiquinol-QH

  16. Consistent PK ResultsOmega-3 EPA/DHA OmegaChoice® in the VESIsorb® delivery system turns concentrated Omega-3 EPA/DHA into water soluble colloidal droplets increasing absorption and broadening the possible applications. A pharmacokinetic pilot study comparing OmegaChoice® 90 Concentrated Omega-3 EPA to the same OmegaChoice™ 90 in the VESIsorb® delivery system demonstrated an increase of 567% in peak blood levels (cmax) of EPA. The relative bioavailability calculated using the area under the curve (AUC 01-12h) was also increase by 487%.

  17. Delivers Maximum Benefits • Consistent advantage of optimal performance under all conditions • Absorption & bioavailability impacted by • Aging population = nutrient absorption declines with age • Low-Fat Diet…see Omthera study Lovaza vs. Epanova • Sickness & Stress negatively impact absorption • More standard capsules = < efficient absorption

  18. COMPETING CoQ10 PRODUCT OIL DROPS SITTING ON WATER DOES NOT GO INTO SOLUTION SEPARATION OF COMPONENTS (NO EMULSIFICATION) COMPLETELY HOMOGENOUS COLLOIDAL SOLUTION! COLLOIDAL DROPLET FORMATION 100% IN SOLUTION!

  19. STANDARD TG OMEGA-3 PRODUCT OIL DROPS SITTING ON WATER DOES NOT GO INTO SOLUTION SEPARATION OF COMPONENTS (NO EMULSIFICATION) COMPLETELY HOMOGENOUS COLLOIDAL SOLUTION! COLLOIDAL DROPLET FORMATION 100% IN SOLUTION!

  20. Leading CoQ10 and QH Ubiquinol Supplement Brands

  21. Homogeneous Delivery System Homogenous versus Heterogeneous Speed of conversion Stability Reproducibility for consistency at the consumer level SourceOne TocoSource® vs. Patented Competitive Tocotrienols

  22. VESIsorb® Fluid Droplets - Cryo Electron Micrograph

  23. VESIFACT HOLDS OVER 40 INTERNATIONAL PATENTS AND PATENTS-PENDING IN OVER 20 COUNTRIES Vesifact Intellectual Property (IP) and Know How

  24. The following listing is an overview of key U.S and European VESIsorb®oral and topical patents for both pharmaceutical and nutraceutical formulations. Additionally we have patents and patents pending in  Japan, China, Hong Kong, Korea, Singapore, Brazil, India, Indonesia, Mexico, Philippines, Russia, Thailand, Taiwan and Argentina. Vesifact Patents & Patent Applications: • Europe patent 1,249,502…”Microemulsion-preconcentrates, microemulsions and use of such a composition” • Europe patent 1,249,230…”Microemulsion-preconcentrates, microemulsions comprising coenzyme Q10” for oral and topical application • Europe patent 852,941…”Nanodispersion cosmetic composition” for topical applications ; any cosmetic active is a candidate • U.S. patent 5,997,888…”Cosmetic preparations” for improved absorption in topical applications; any cosmetic active is a candidate • Europe patent 1,249,231…”Pharmaceutical formulations containing anti-inflammatory active ingredients and the use of said formulations” • Europe patent 956,851…”Use of nanodispersions in cosmetic end formulations” for improved absorption in topical applications; any cosmetic active is a candidate • U.S. patent 7,008,638…”Use of nanodispersions in cosmetic end formulations” • Europe patent 956,853…”Use of nanodispersions in pharmaceutical end formulations for oral and topical applications of any pharmaceutical ingredients” • U.S. patent 7,081,253…”Use of nanodispersions in pharmaceutical end formulations for oral and topical applications of any pharmaceutical ingredients”

  25. What Do Consumers Want? To take fewer capsules To take smaller capsules To receive the maximum benefits from their supplements Greater bioavailability & absorption …With is more!

  26. The VESIsorb® Solution Size Matters With VESIsorb®, you need less to achieve more. Fewer soft gels in your daily regimen to achieve better results. =

  27. VESIsorb® technology has a green impact on the environment. • The efficient use of resources results in fewer bottles, less packaging waste and reduced transportation needs. • By increasing bioactive absorption, like CoQ10, this in turn reduces the number of soft gels needed per day to achieve blood plasma levels for optimum health and wellness.

  28. Patented, clinically proven formulations in leading brands

  29. Advanced Innovative technologies

  30. Summary

More Related